Calcium

Lancet

Volumn 352, Issue 9124, 1998, Pages 306-311

  Bushinsky, David A ^a   Monk, Rebeca D ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCITRIOL; CALCIUM; CALCIUM CHANNEL STIMULATING AGENT; CALCIUM ION; CITRATE CALCIUM; CLODRONIC ACID; COLECALCIFEROL; ERGOCALCIFEROL; ESTROGEN; ETIDRONIC ACID; GALLIUM NITRATE; GLUCOCORTICOID; GLUCONATE CALCIUM; LOOP DIURETIC AGENT; MITHRAMYCIN; PAMIDRONIC ACID; PARATHYROID HORMONE; THIAZIDE DIURETIC AGENT; VITAMIN D;

AMPOULE; ANEMIA; BONE; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELLULITIS; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG COST; DRUG FORMULATION; HORMONAL REGULATION; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOCALCEMIA; HYPOPARATHYROIDISM; HYPOPHOSPHATEMIA; INFLAMMATION; INTESTINE; KIDNEY; NAUSEA; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; REVIEW; THROMBOCYTOPENIA; HOMEOSTASIS; METABOLISM; PHYSIOLOGY;

CALCIUM; DIAGNOSIS, DIFFERENTIAL; HOMEOSTASIS; HUMANS; HYPERCALCEMIA; HYPOCALCEMIA;

EID: 0032566179     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)12331-5     Document Type: Review

References (31)

1. 1 Bushinsky DA, Krieger NS. Integration of calcium metabolism in the adult. In: Coe FL, Favus MJ, eds. Disorders of bone and mineral metabolism. New York: Raven, 1992: 417-32.
2. 2 Bushinsky DA, Krieger NS. Role of the skeleton in calcium homoeostasis. In: Seldin DW, Giebisch G, eds. The kidney: physiology and pathophysiology. New York: Raven, 1992: 2395-430.
3. 3 Brown EM, Gamba G, Riccardi D, et al. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature 1993; 366: 575-80.
4. 4 Brown EM, Pollak M, Seidman CE, et al. Calcium-ion-sensing cell-surface receptors. N Engl J Med 1995; 333: 234-40.
5. 5 Monk RD, Bushinsky DA. Pathogenesis of idopathic hypercalciuria. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM, eds. Kidney stones: medical and surgical management. Philadelphia: Lippincott-Raven, 1996: 759-72.
6. 6 Sutton RAL, Dirks JH. Disturbances of calcium and magnesium metabolism. In: Brenner BM, Rector FC, eds. The kidney. Philadelphia: Saunders, 1996: 1038-85.
7. 7 Monk RD, Bushinsky DA. Treatment of calcium, phosphorus and magnesium disorders. In: Brady H, Wilcox C, eds. Disorders of fluid, electrolyte and acid-base disorders. Philadelphia: Saunders (in press).
8. 8 Broadus AE. Mineral balance and homeostasis. In: Favus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. Philadelphis: Lippincott-Raven, 1996: 57-63.
9. 9 Bushinsky DA. Homeostasis and disorders of calcium and phosphorus concentration. In: Greenberg A, ed. Primer on kidney diseases. San Diego: Academic, 1998: 106-13.
10. 10 Shane E. Hypercalcemia: pathogenesis, clinical manifestations, differential diagnosis, and management. In: Flavus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. Philadelphia: Lippincott-Raven, 1996: 177-81.
11. 11 Bilezikian JP. Management of hypercalcemia. J Clin Endocrinol Metab 1993; 77: 1445-49.
12. 12 Complete Proceedings of the Consensus Development Conference. Diagnosis and management of asymptomatic primary hyperparathyroidism. J Bone Miner Res 1991; 6 (suppl 2): S1-S165.
13. 13 Bilezikian JP. Management of acute hypercalcemia. N Engl J Med 1992; 326: 1196-203.
14. 14 Mundy GR, Guise TA. Hypercalcemia of malignancy. Am J Med 1997; 103: 134-45.
15. 15 Kovacs CS, MacDonald SM, Chik CL, Bruera E. Hypercalcemia of malignancy in the palliative care patient: a treatment strategy. J Pain Symptom Management 1995; 10: 224-32.
16. 16 Budayr AA, Nissenson RA, Klein RF, et al. Increased serum levels of a parathyroid-like protein in malignancy-associated hypercalcemia. Ann Intern Med 1989; 111: 807-12.
17. 17 Bushinsky DA. The contribution of acidosis to renal osteodystrophy. Kidney Int 1995; 47: 1816-32.
18. 18 Shane E. Medical management of asymptomatic primary hyperparathyroidism. J Bone Miner Res 1991; 6 (S2): S131-34.
19. 19 Silverberg SJ, Bone HG, Marriott TB, et al. Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism. N Engl J Med 1997; 337: 1506-10.
20. 20 Marcus R. Etrogens and progestins in the management of primary hyperparathyroidism. J Bone Miner Res 1991; 6 (S2): S125-29.
21. 21 Raue F, Pecherstorfer M. Drug therapy of hypercalcemia due to malignancy. Rec Results Cancer Res 1994; 137: 138-60.
22. 22 Body JJ, Coleman RE, Piccart M. Use of bisphosphonates in cancer patients. Cancer Treat Rev 1996; 22: 265-87.
23. 23 Singer FR, Minoofar PN, Bisphosphonates in the treatment of disorders of mineral metabolism. Adv Endocrinol Metab 1995; 6: 259-88.
24. 24 Fleisch H. Bisphosphonates. Pharmacology and use in the treatment of tumor-induced hypercalcemia and metastatic bone disease. Drugs 1991; 42: 919-44.
25. 25 Berenson JR, Lichtenstein A, Porter L, et al. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. N Engl J Med 1996; 334: 488-93.
26. 26 Shane E. Hypocalcemia: pathogenesis, differential diagnosis, and management. In: Favus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. Philadelphia: Lippincott-Raven, 1996: 217-19.
27. 27 Reber PM, Heath H III. Hypocalcemic emergencies. Med Clin N Am 1995; 79: 93-106.
28. 28 Tohme JF, Bilezikian JP. Hypocalcemic emergencies. Endocrinol Metab Clin N Am 1993; 22: 363-75.
29. 29 Reber PM, Heath H III. Hypocalemic emergencies. Med Clin N Am 1995; 79: 93-106.
30. 30 Pak CYC. Calcium disorders: hypercalcemia and hypocalcemia. In: Kokko JP, Tannen RL, eds. Fluids and electrolytes. Philadelphia: WB Saunders, 1990: 596-630.
31. 31 Hruska KA, Connolly J. Hyperphosphatemia and hypophosphatemia. In: Favus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. Philadelphia: Lippincott-Raven, 1996: 238-45.